These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1778220)

  • 81. Clearance of iopamidol, a non-ionic contrast medium, by CAPD in patients with end-stage renal failure.
    Donnelly PK; Burwell N; McBurney A; Ward JW; Walls J; Watkin EM
    Br J Radiol; 1992 Dec; 65(780):1108-13. PubMed ID: 1286420
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Continuous ambulatory peritoneal dialysis (CAPD). 3 years' therapeutic experience in 100 patients].
    Rottembourg J; de Groc F; Jacq D; Issad B; El Shahat Y; Aqraflotis A; Seidler A; Legrain M
    Z Urol Nephrol; 1983 Mar; 76(3):191-201. PubMed ID: 6858416
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Inflammatory effects of peritoneal dialysis: evidence of systemic monocyte activation.
    Libetta C; De Nicola L; Rampino T; De Simone W; Memoli B
    Kidney Int; 1996 Feb; 49(2):506-11. PubMed ID: 8821837
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Plasma interleukin-18 levels in chronic renal failure and continuous ambulatory peritoneal dialysis.
    Chiang CK; Hsu SP; Pai MF; Peng YS; Ho TI; Liu SH; Hung KY; Tsai TJ; Hsieh BS
    Blood Purif; 2005; 23(2):144-8. PubMed ID: 15677863
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Immunohistochemical detection of an AGE, a ligand for macrophage receptor, in peritoneum of CAPD patients.
    Nakamura S; Tobita K; Tachikawa T; Akamatsu S; Ohno Y; Kan A; Katsuragawa M; Yasumura K; Miyazaki S; Sakai S; Morita T; Hirashawa Y; Niwa T
    Kidney Int Suppl; 2003 May; (84):S152-7. PubMed ID: 12694334
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Soluble transferrin receptor is not a reliable marker of iron deficiency in pediatric CAPD patients.
    Bakkaloglu SA; Ekim M; Tümer N; Akar N; Uysal Z
    Perit Dial Int; 2002; 22(5):621-5. PubMed ID: 12455576
    [No Abstract]   [Full Text] [Related]  

  • 87. Gastric acid and histamine secretion in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Man WK; Cassidy MJ; Spencer J
    Agents Actions; 1994 Jun; 41 Spec No():C93-4. PubMed ID: 7526666
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The serum complement system in children on continuous ambulatory peritoneal dialysis.
    Reddingius RE; Schröder CH; Daha MR; Monnens LA
    Perit Dial Int; 1993; 13(3):214-8. PubMed ID: 8369352
    [TBL] [Abstract][Full Text] [Related]  

  • 89. An outpatient maneuver to treat bloody effluent during continuous ambulatory peritoneal dialysis (CAPD).
    Goodkin DA; Benning MG
    Perit Dial Int; 1990; 10(3):227-9. PubMed ID: 2094462
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Restoration of the cellular thiol status of peritoneal macrophages from CAPD patients by the flavonoids silibinin and silymarin.
    Täger M; Dietzmann J; Thiel U; Hinrich Neumann K; Ansorge S
    Free Radic Res; 2001 Feb; 34(2):137-51. PubMed ID: 11264891
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Purification of human complement factor D from the peritoneal fluid of patients on chronic ambulatory peritoneal dialysis.
    Catana E; Schifferli JA
    J Immunol Methods; 1991 Apr; 138(2):265-71. PubMed ID: 2033278
    [TBL] [Abstract][Full Text] [Related]  

  • 92. HLA-DR expression on human peritoneal macrophages in vivo and in vitro.
    Bos HJ; Keizer GD; vd Muijsenberg AJ; Beelen RH
    Cell Biol Int Rep; 1990 Jun; 14(6):499-508. PubMed ID: 2196125
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Diarrhea induced by CAPD. A new complication following initiation of CAPD?
    Prakashan KP; Mathew MT
    Perit Dial Int; 1998; 18(5):536. PubMed ID: 9848636
    [No Abstract]   [Full Text] [Related]  

  • 94. Antibacterial activity of the dialysates and sera during treatment with chemotherapeutic combinations in continuous ambulatory peritoneal dialysis (CAPD).
    Beader N; Zagar Z
    J Chemother; 1989 Aug; 1(4):244-7. PubMed ID: 2809691
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Increased salivary concentration of human epidermal growth factor in patients undergoing CAPD.
    Dagogo-Jack S; Rodger RS; Kendall-Taylor P
    Perit Dial Int; 1991; 11(3):270-3. PubMed ID: 1912022
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The problem of continuous ambulatory peritoneal dialysis (CAPD) in Belgium.
    Lameire N
    Acta Clin Belg; 1986; 41(6):375-80. PubMed ID: 3577573
    [No Abstract]   [Full Text] [Related]  

  • 97. Glycosylation and Characterization of Human Transferrin in an End-Stage Kidney Disease.
    Miljuš G; Penezić A; Pažitná L; Gligorijević N; Baralić M; Vilotić A; Šunderić M; Robajac D; Dobrijević Z; Katrlík J; Nedić O
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731843
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The impact of changes in extracellular-to-intracellular water ratio on pulse wave velocity in prevalent CAPD patients: a longitudinal study.
    Gu Y; Axelsson J; Zeng J; Chen HM; Cheng LT; Wang T
    Perit Dial Int; 2008; 28(4):412-5. PubMed ID: 18556386
    [No Abstract]   [Full Text] [Related]  

  • 99. CAPD in a patient with spinal cord transection--a minefield of disasters.
    Fine A; Anderson BA; Kirkpatrick J
    Perit Dial Int; 1993; 13(1):69-71. PubMed ID: 8443286
    [No Abstract]   [Full Text] [Related]  

  • 100. Effects of CAPD applications on pulmonary function.
    Gökbel H; Yeksan M; Dogan E; Gündogan F; Uzun K
    Perit Dial Int; 1998; 18(3):344-5. PubMed ID: 9663907
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.